H|T: The Healthtech Times – A bumpy ride for Peloton
Plus: Zymeworks stock hits three-year low.
Plus: Zymeworks stock hits three-year low.
BenchSci says its tech is used by 16 of the top 20 pharmaceutical companies.
Plus: Talkspace faces class action alleging it misled investors ahead of SPAC deal.
The partnership gives Amplitude access to Alberta’s sizeable AI sector.
The startup is entering clinical trials, and needs to gain regulatory approval.
Startups on the 2021 list made major financing deals and exits.
Plus: The Elizabeth Holmes verdict.
Wello’s 350 customers include Fortune 100 companies
The new service represents Telus Health’s latest move into the digital healthcare space.
The Toronto company is part of a growing wave of fertility-focused tech startups.
The startup plans to use its Series A capital to expand into the US.
LifeSpeak’s short-form base shelf prospectus comes less than six months after its TSX debut.
Virtual care is here to stay.
League will watch the ball drop with a billion-dollar valuation.
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using…